Manager × security

Patient Capital Management, LLC UBS holdings history

Who else holds this security? →

UBS GROUP AG-REG · CUSIP H42097107 · CIK 1854794

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Patient Capital Management, LLC reported 953.73K UBS (shares), valued at $47.27M, or 1.57% of its reported non-derivative portfolio. Filed 2026-08-13.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
1.57%
Shares
953.73K
953,734
Reported value
$47.27M
USD

Shares decreased 23.21%; reported value decreased 2.59%, and weight changed -0.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20261.57%953,734SEC filing ↗Filed Aug 13, 2026
Q1 20261.81%1,241,955SEC filing ↗Filed May 14, 2026
Q4 20252.12%1,187,326SEC filing ↗Filed Feb 13, 2026
Q3 20252.46%1,500,849SEC filing ↗Filed Oct 30, 2025
Q2 20252.96%1,937,639SEC filing ↗Filed Aug 13, 2025
Q1 20253.22%2,043,053SEC filing ↗Filed May 14, 2025
Q4 20242.86%2,042,420SEC filing ↗Filed Feb 14, 2025
Q3 20243.07%2,022,019SEC filing ↗Filed Nov 14, 2024
Q2 20243.18%2,028,937SEC filing ↗Filed Aug 14, 2024
Q1 20243.50%2,339,900SEC filing ↗Filed May 15, 2024
Q4 20234.01%2,450,937SEC filing ↗Filed Feb 14, 2024
Q3 20233.59%2,482,612SEC filing ↗Filed Nov 14, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20233.59%2,482,612$61.20MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 14, 2023
Q4 20234.01%2,450,937$75.73MShares decreased 1.28%; reported value increased 23.76%, and weight changed +0.42 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2024
Q1 20243.50%2,339,900$71.88MShares decreased 4.53%; reported value decreased 5.09%, and weight changed -0.51 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20243.18%2,028,937$59.93MShares decreased 13.29%; reported value decreased 16.62%, and weight changed -0.32 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20243.07%2,022,019$62.50MShares decreased 0.34%; reported value increased 4.28%, and weight changed -0.11 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20242.86%2,042,420$61.93MShares increased 1.01%; reported value decreased 0.92%, and weight changed -0.21 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20253.22%2,043,053$62.58MShares increased 0.03%; reported value increased 1.05%, and weight changed +0.36 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2025
Q2 20252.96%1,937,639$65.53MShares decreased 5.16%; reported value increased 4.72%, and weight changed -0.26 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2025
Q3 20252.46%1,500,849$61.53MShares decreased 22.54%; reported value decreased 6.10%, and weight changed -0.50 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 30, 2025
Q4 20252.12%1,187,326$54.99MShares decreased 20.89%; reported value decreased 10.64%, and weight changed -0.34 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2026
Q1 20261.81%1,241,955$48.52MShares increased 4.60%; reported value decreased 11.75%, and weight changed -0.31 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2026
Q2 20261.57%953,734$47.27MShares decreased 23.21%; reported value decreased 2.59%, and weight changed -0.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2026
Patient Capital Management, LLC · UBS GROUP AG-REG

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1854794","quarter":"2026Q2","cusip":"H42097107"}

get_institutional_manager_history
{"cik":"1854794","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.